In November, the Boston-based biotech firm Karuna Therapeutics submitted its new schizophrenia medication, called KarXT, to the US Food and Drug Administration for approval. If the agency gives KarXT ...
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...
Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...
The severity and symptoms of schizophrenia vary from person to person. Symptoms like hallucinations (seeing or hearing things that aren’t there), delusions (steadfast beliefs in things that are ...
Everyday Health on MSN
Cognitive Symptoms of Schizophrenia: Why They Happen and What Can Be Done About Them
Cognitive issues are core symptoms of schizophrenia. More than 80 percent of people with schizophrenia have cognitive symptoms of some kind. They’re one of the main obstacles to managing schizophrenia ...
When I imagine schizophrenia as an image, I see a storm. A storm that sweeps someone into a new reality creating voices, visions, and unshared beliefs. I picture branches tossed around reflecting the ...
What if schizophrenia does not have a singular cause? I recently read an article in the New Yorker by Rachel Aviv [1] about recovery from schizophrenia. It wasn’t about drug intervention. The premise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback